IQVIA LTD.
Formerly known as Quintiles, the company operates as a UK subsidiary of the US-listed IQVIA Holdings Inc, providing clinical trial management, healthcare data analytics, and contract research services to the life sciences sector.
Get an alert when IQVIA LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£102m
+105.4% highest in 3 filed years
Net assets
£2.5bn
-35.9% lowest in 3 filed years
Employees
3,894
+6.9% highest in 3 filed years
Profit before tax
-£1.3bn
-485.5% lowest in 3 filed years
Net assets
3-year trend · vs Technology median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £2,752,678,000 | £3,004,120,000 | £3,044,069,000 | +1.3% | |
| Operating profit | £255,841,000 | £292,556,000 | £281,975,000 | -3.6% | |
| Profit before tax | £582,166,000 | £344,243,000 | -£1,327,009,000 | -485.5% | |
| Net profit | £539,790,000 | £307,743,000 | -£1,389,883,000 | -551.6% | |
| Cash | £22,203,000 | £49,714,000 | £102,099,000 | +105.4% | |
| Total assets less current liabilities | £3,713,068,000 | £4,497,417,000 | £2,750,465,000 | -38.8% | |
| Net assets | £3,713,068,000 | £3,954,478,000 | £2,534,630,000 | -35.9% | |
| Equity | £3,713,068,000 | £3,954,478,000 | £2,534,630,000 | -35.9% | |
| Average employees | 3,615 | 3,643 | 3,894 | +6.9% | |
| Wages | £277,694,000 | £288,156,000 | £294,845,000 | +2.3% | |
| Directors' remuneration | £4,491,000 | £5,378,000 | £3,792,000 | -29.5% | |
| Directors' pension contributions | £48,000 | £67,000 | — | — | |
| Highest paid director | — | £1,964,000 | £2,076,000 | +5.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 9.3% | 9.7% | 9.3% | |
| Net margin | 19.6% | 10.2% | -45.7% | |
| Return on capital employed | 6.9% | 6.5% | 10.3% | |
| Gearing (liabilities / total assets) | 19.6% | 12.1% | 44.0% | |
| Current ratio | 0.88x | 0.61x | 0.73x | |
| Interest cover | 6.29x | 3.58x | 2.95x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- IQVIA LTD. 2017-11-03 → present
- QUINTILES LIMITED 2000-12-29 → 2017-11-03
- QUINTILES SCOTLAND LIMITED 1995-02-15 → 2000-12-29
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The ultimate parent company, IQVIA Holdings Inc., has confirmed that it will continue to provide such financial support as necessary to enable the company to meet its financial obligations as they fall due for a period of at least 12 months from the date of signing of these financial statements.”
Group structure
- IQVIA LTD. · parent
- Q Squared Solutions Holdings Limited 60%
- Clintec Luxembourg S.A. 100%
- Clinical Lab Minority Shareholder Limited 100%
- IQVIA RDS Austria GmbH 100%
Significant events
- “On 11 June 2025, the company acquired the shares of Medicines Evaluation Unit Limited and CRO Solutions Limited.”
- “On 1 July 2025, the company acquired the trade of PharmaReview Limited and also the entire issued share capital of Apira Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-21 | — | — |
| BERKSHIRE, James Grant | Director | 2020-02-07 | Jun 1973 | British |
| HIRA, Pauljit Singh | Director | 2026-07-13 | May 1976 | British |
| MELIA, Richard | Director | 2026-07-13 | Sep 1981 | British |
| RANDALL, Kerry Louise | Director | 2023-11-28 | Jul 1980 | British |
| SHEPPARD, Timothy Peter | Director | 2020-02-07 | Jan 1971 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WILSON, Michael Norman | Secretary | 1995-02-15 | 2014-02-28 |
| HALCO SECRETARIES LIMITED | Corporate Secretary | 2018-04-10 | 2023-06-21 |
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 1995-02-15 | 1995-02-15 |
| GILLINGS, Dennis Barry, Dr | Director | 1995-02-15 | 1999-12-23 |
| GOODACRE, John | Director | 1999-12-23 | 2015-12-17 |
| KOTCHIE, Natalia Alexandra | Director | 2020-10-08 | 2026-07-13 |
| LATTIMORE, Barry Keith | Director | 2018-12-18 | 2020-05-29 |
| MACDONALD, Alasdair | Director | 2000-07-31 | 2018-12-31 |
| REYNDERS, Ludo, Dr | Director | 1995-02-15 | 2004-06-10 |
| TURLAND, Kevin John | Director | 2014-02-28 | 2026-08-18 |
| WILSON, Michael Norman | Director | 1995-02-15 | 2014-02-28 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 1995-02-15 | 1995-02-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Quintiles Holdings | Legal person | Shares 75–100% | 2016-04-06 | Ceased 2016-04-06 |
| Iqvia Rds Holdings | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 174 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-12-12 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-28 | AA | accounts | Accounts with accounts type full | |
| 2026-08-18 | TM01 | officers | Termination director company with name termination date | |
| 2026-07-26 | AP01 | officers | Appoint person director company with name date | |
| 2026-07-24 | TM01 | officers | Termination director company with name termination date | |
| 2026-07-24 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-08 | AA | accounts | Accounts with accounts type full | |
| 2025-07-09 | CH01 | officers | Change person director company with change date | |
| 2025-02-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-12 | RESOLUTIONS | resolution | Resolution | |
| 2024-12-09 | SH01 | capital | Capital allotment shares | |
| 2024-09-23 | AA | accounts | Accounts with accounts type full | |
| 2024-02-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-06 | CH01 | officers | Change person director company with change date | |
| 2023-10-09 | AD02 | address | Change sail address company with old address new address | |
| 2023-10-06 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2023-10-06 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-04-27 | SH19 | capital | Capital statement capital company with date currency figure |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 1
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.